Fig. 6From: Achieving optimal response at 12 months is associated with a better health-related quality of life in patients with chronic myeloid leukemia: a prospective, longitudinal, single center studyFailure-free survival, progression-free survival, and overall survival by treatment response at 3, 6, and 12 monthsBack to article page